Bregje Mol

784 total citations
15 papers, 152 citations indexed

About

Bregje Mol is a scholar working on Epidemiology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bregje Mol has authored 15 papers receiving a total of 152 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Hepatology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bregje Mol's work include Liver Diseases and Immunity (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Gallbladder and Bile Duct Disorders (6 papers). Bregje Mol is often cited by papers focused on Liver Diseases and Immunity (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Gallbladder and Bile Duct Disorders (6 papers). Bregje Mol collaborates with scholars based in Netherlands, Finland and Sweden. Bregje Mol's co-authors include Cyriel Y. Ponsioen, Dick J. Tinga, Peter Bossuyt, Fulco van der Veen, W.M. Ankum, Petra J. Hajenius, Ailsa Hart, Judith E. Bosmans, Willem A. Bemelman and Geert D’Haens and has published in prestigious journals such as Gastroenterology, Hepatology and Gut.

In The Last Decade

Bregje Mol

14 papers receiving 148 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bregje Mol Netherlands 5 73 62 61 40 30 15 152
Esther Orlanski‐Meyer Israel 8 96 1.3× 121 2.0× 13 0.2× 67 1.7× 10 0.3× 22 185
Theodore Nanidis United Kingdom 6 175 2.4× 193 3.1× 138 2.3× 247 6.2× 5 0.2× 9 381
Jessica J. Lee United States 5 98 1.3× 96 1.5× 11 0.2× 55 1.4× 17 0.6× 8 199
Seung Man Cho South Korea 8 73 1.0× 44 0.7× 8 0.1× 94 2.4× 9 0.3× 17 171
Jerico del-Rosario United States 3 64 0.9× 83 1.3× 11 0.2× 53 1.3× 14 0.5× 4 154
Alyson L Ross Australia 9 78 1.1× 121 2.0× 104 1.7× 135 3.4× 2 0.1× 17 208
Birgit Kaltz Germany 7 103 1.4× 145 2.3× 14 0.2× 62 1.6× 17 0.6× 7 199
Muhammad A. Akhtar United Kingdom 6 26 0.4× 18 0.3× 74 1.2× 20 0.5× 30 1.0× 16 276
Bijay Baburajan United Kingdom 3 32 0.4× 58 0.9× 68 1.1× 11 0.3× 10 0.3× 6 107
Milind Chitnis South Africa 7 27 0.4× 15 0.2× 9 0.1× 93 2.3× 13 0.4× 17 174

Countries citing papers authored by Bregje Mol

Since Specialization
Citations

This map shows the geographic impact of Bregje Mol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bregje Mol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bregje Mol more than expected).

Fields of papers citing papers by Bregje Mol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bregje Mol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bregje Mol. The network helps show where Bregje Mol may publish in the future.

Co-authorship network of co-authors of Bregje Mol

This figure shows the co-authorship network connecting the top 25 collaborators of Bregje Mol. A scholar is included among the top collaborators of Bregje Mol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bregje Mol. Bregje Mol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Holmer, Magnus, Michael Ingre, Martti Färkkilâ, et al.. (2025). Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study. Hepatology. 83(1). 21–29.
2.
Mol, Bregje, et al.. (2025). Epidemiological and economical burden of cholestatic liver disease. Hepatology. 82(4). 813–833. 1 indexed citations
3.
Molinaro, Antonio, Bregje Mol, Cyriel Ponsioen, et al.. (2025). Surveillance of primary sclerosing cholangitis – a comparison of scheduled or on-demand ERCP with annual MRI surveillance: a multicenter study. Endoscopy. 57(5). 431–440. 1 indexed citations
4.
Mol, Bregje, Martti Färkkilâ, Trine Folseraas, et al.. (2024). DOP14 Proctocolectomy is associated with improved transplant-free survival in patients with primary sclerosing cholangitis: results from a pooled collaborative international study. Journal of Crohn s and Colitis. 18(Supplement_1). i97–i98. 2 indexed citations
5.
Wit, Koos de, Bregje Mol, Lonneke A. van Vught, et al.. (2024). Neurofilament light chain but not glial fibrillary acidic protein is a potential biomarker of overt hepatic encephalopathy in patients with cirrhosis. Annals of Hepatology. 29(3). 101496–101496. 2 indexed citations
6.
Mol, Bregje, Johannes A. Bogaards, Rinse K. Weersma, et al.. (2023). Health‐related quality of life in patients with primary sclerosing cholangitis: A longitudinal population‐based cohort study. Liver International. 43(5). 1056–1067. 5 indexed citations
7.
Mol, Bregje, Annemarie de Vries, Adriaan van der Meer, et al.. (2023). OP10 Proctocolectomy with permanent ileostomy is associated with better transplant-free survival in patients with primary sclerosing cholangitis: a retrospective cohort study. Journal of Crohn s and Colitis. 17(Supplement_1). i16–i16. 3 indexed citations
8.
Mol, Bregje, Jorn Goet, Sanne N. van Munster, et al.. (2022). Disease burden in primary sclerosing cholangitis in the Netherlands: A long‐term follow‐up study. Liver International. 43(3). 639–648. 11 indexed citations
9.
Mol, Bregje, Johannes A. Bogaards, Rinse K. Weersma, et al.. (2022). Health-related quality of life in patients with primary sclerosing cholangitis: a longitudinal population-based cohort study. Journal of Hepatology. 77. S338–S339. 3 indexed citations
10.
Stevens, Toer, Geert D’Haens, Christianne J. Buskens, et al.. (2020). OP03 Reduced need for surgery and medical therapy after early ileocaecal resection for Crohn’s disease: Long-term follow-up of the LIR!C trial. Journal of Crohn s and Colitis. 14(Supplement_1). S003–S004. 4 indexed citations
11.
Stevens, Toer, Geert D’Haens, Christianne J. Buskens, et al.. (2020). 284 EARLY LAPAROSCOPIC ILEOCECAL RESECTION DECREASES NEED FOR MEDICAL TREATMENT AND SURGERY IN INFLAMMATORY ILEOCECAL CROHN'S DISEASE: LONG-TERM FOLLOW UP OF THE LIR!C TRIAL. Gastroenterology. 158(6). S–55. 1 indexed citations
12.
Groof, E. Joline de, Toer Stevens, Emma J. Eshuis, et al.. (2019). Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn’s disease: the LIR!C Trial. Gut. 68(10). 1774–1780. 60 indexed citations
13.
Rutten, Marianne J., Hannah S. van Meurs, Toon Van Gorp, et al.. (2015). LAPAROSCOPY TO PREDICT THE RESULT OF PRIMARY CYTOREDUCTIVE SURGERY IN ADVANCED OVARIAN CANCER (LAPOVCA) : A MULTICENTRE RANDOMISED CONTROLLED TRIAL. International Journal of Gynecological Cancer. 25(9). 102–103. 1 indexed citations
15.
Mol, Bregje, Dick J. Tinga, Petra J. Hajenius, et al.. (1998). Fertility after conservative and radical surgery for tubal pregnancy. Human Reproduction. 13(7). 1804–1809. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026